StimolIrpinia: a multimedia memory-based tool to support cognitive rehab after severe brain injury
Official title: Feasibility and Acceptability of StimolIrpinia for Cognitive Rehabilitation After Severe Acquired Brain Injury
Run by Fondazione Don Carlo Gnocchi ETS · NCT07718321 · Data updated 2026-11-12
This pilot test checks if StimolIrpinia, a local memory-rich media repository, is easy to use and helpful for people with severe acquired brain injury during their rehab.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Fondazione Don Carlo Gnocchi ETS Academic / other |
| Locations | 1 site (Sant'Angelo dei Lombardi, AV) |
| Status | Recruiting |
| Started | June 22, 2026 |
| Main results expected | August 22, 2027 |
| Study ends | August 22, 2027 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT07718321 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with severe acquired brain injury, stable enough for rehabilitation, and residing in or having ties to the Irpinia area.
✕Probably not a fit
Patients without access to the local context or those with severe medical or language barriers that prevent participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center pilot study will assess feasibility, usability, acceptability, and preliminary stimulus validation of StimolIrpinia, a multimedia repository of locally relevant autobiographical stimuli. Rehabilitation professionals will receive standardized training to incorporate StimolIrpinia into six 30-minute cognitive rehabilitation sessions over two weeks as an adjunct to routine care. Healthy volunteers will rate the stimuli for autobiographical evoke-ness, familiarity, emotional activation, and pleasantness, informing stimulus selection. The materials are designed to be flexible tools within standard rehabilitation practices and are not medical software or devices. The study aims to determine whether the repository can be feasibly integrated into real-world neurorehabilitation for adults with severe acquired brain injury living in the Irpinia region.
Why it matters
Potential benefit: If successful, StimolIrpinia could make cognitive rehabilitation activities more ecologically valid and personally meaningful for patients with severe brain injury.
How similar studies have gone: Previous neurorehabilitation work suggests ecologically valid, person-centered stimuli can support engagement and practice, though this exact repository approach is novel in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients With Severe Acquired Brain Injury - Inclusion Criteria * Age between 18 and 75 years. * Level of Cognitive Functioning (LCF) score \>= 5 at study entry. * Stable clinical diagnosis, assessed by at least four repeated LCF evaluations within a 1-week time window. * History of severe acquired brain injury of traumatic, anoxic, vascular, or mixed etiology, defined as Glasgow Coma Scale score \<= 8 for at least 24 hours after brain injury. * Pathological performance on at least one Oxford Cognitive Screening (OCS) subscale. * Having lived for a prolonged period in the Irpinia area, including Partenio, Valle Ufita-Baronia, Serinese-Solofrana, Alta Irpinia, Vallo di Lauro-Baianese, and/or Terminio-Cervialto. * Written informed consent signed by the patient or by the patient's legal representative. Patients With Severe Acquired Brain Injury - Exclusion Criteria • Severe medical conditions that may prevent participation in rehabilitation sessions, including severe language deficits incompatible with understanding instructions, severe cardiovascular instability, photosensitive or reflex epilepsy, and disabling visual or hearing deficits. Rehabilitation Professionals/Operators - Inclusion Criteria * Age \>= 18 years. * Proven experience in neuromotor and/or cognitive rehabilitation of patients with severe acquired brain injury. * Written informed consent to participate in the study. Rehabilitation Professionals/Operators - Exclusion Criteria • Participation in the development of the StimolIrpinia repository, resulting in prior familiarity with the repository.
Where it's running
-
Polo Specialistico Riabilitativo Fondazione Don Gnocchi
Sant'Angelo dei Lombardi, Av, Italy Recruiting
Study contacts
- Study coordinator: Alfonso Magliacano
- Email: amagliacano@dongnocchi.it
- Phone: 393387389414
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Home-based gamma-tACS with personalized cognitive training for mild Alzheimer's disease
This study tests a home-delivered combination of gamma-frequency tACS and individualized memory training to see if it helps people with mild Alzheimer's disease.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.